140 related articles for article (PubMed ID: 7697911)
1. Longer local retention of adoptively transferred T-LAK cells correlates with lesser adhesion molecule expression than NK-LAK cells.
Yamamoto T; Yoneda K; Osaki T; Yoshimura N; Akagi N
Clin Exp Immunol; 1995 Apr; 100(1):13-20. PubMed ID: 7697911
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
5. Infiltration patterns of short- and long-term cultured A-NK and T-LAK cells following adoptive immunotherapy.
Kjaergaard J; Hokland M; Nannmark U; Hokland P; Basse P
Scand J Immunol; 1998 Jun; 47(6):532-40. PubMed ID: 9652820
[TBL] [Abstract][Full Text] [Related]
6. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
Savary CA; Lotzová E
Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
9. Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemia.
Lotzová E; Savary CA; Totpal K; Schachner J; Lichtiger B; McCredie KB; Freireich EJ
Leuk Res; 1991; 15(4):245-54. PubMed ID: 2030606
[TBL] [Abstract][Full Text] [Related]
10. Isolation of human NK cells and generation of LAK activity.
Whiteside TL
Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
[TBL] [Abstract][Full Text] [Related]
11. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium.
Irjala H; Salmi M; Alanen K; Grénman R; Jalkanen S
J Immunol; 2001 Jun; 166(11):6937-43. PubMed ID: 11359855
[TBL] [Abstract][Full Text] [Related]
12. Transendothelial migration activity of lymphokine-activated killer (LAK) cells.
Kitayama J; Juji T; Atomi Y; Kuroda A; Muto T; Kobayashi M; Mitsui Y; Minami M
J Immunol; 1993 Aug; 151(3):1663-72. PubMed ID: 8335950
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.
Basse P; Herberman RB; Nannmark U; Johansson BR; Hokland M; Wasserman K; Goldfarb RH
J Exp Med; 1991 Aug; 174(2):479-88. PubMed ID: 1856630
[TBL] [Abstract][Full Text] [Related]
14. Increased processing of lymphocyte function-associated antigen-1 in human natural killer cells stimulated with IL-2.
Umehara H; Minami Y; Domae N; Bloom ET
Int Immunol; 1994 Jul; 6(7):1071-80. PubMed ID: 7947458
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells.
Umehara H; Takashima A; Minami Y; Bloom ET
Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.
Yoneda K; Osaki T; Yamamoto T; Ueta E
Clin Exp Immunol; 1993 Aug; 93(2):229-36. PubMed ID: 8348749
[TBL] [Abstract][Full Text] [Related]
17. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
20. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Falk CS; Noessner E; Weiss EH; Schendel DJ
Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
